BRAF and melanoma: These data argue for a counter-regulatory function of PTPIP51 in dedifferentiating melanocytes trying to reduce the stimulation by PTPIP51 interaction on BRAF level displaying lowest levels in dysplastic nevi and somewhat higher levels in malignant melanomas.